YD Bio Limited Ordinary Shares

YDES
$12.38 +1.04 (9.22%)
🚫 YD Bio Limited Ordinary Shares does not pay dividends

Company News

YD Bio Limited Expands U.S. Presence with Newly Planned California Facilities and Operations Center
GlobeNewswire Inc. • Dr. Ethan Shen • December 16, 2025

YD Bio Limited plans to establish a new U.S. operations center in California to accelerate clinical development, regulatory engagement, and commercial access for cancer diagnostics and exosome-based therapeutics.

Related Companies